TEL AVIV, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative ...
TEL AVIV, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative ...
Nasus Pharma (NSRX) announced the execution of comprehensive agreements with Aptar France S.A.S. and AptarGroup (ATR) to support the ongoing clinical development and planned commercialization of NS002 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback